Worldwide Clinical Trials’ Aman Khera Recognized Among Pharmavoice 100 Most Inspiring People


August 3, 2021

Vice President, Global Head of Regulatory Strategy Honored for Innovative and Inspiring  Work to Elevate Regulators’ Strategic Role in Drug and Device Development

Research Triangle Park, N.C. –  August 3, 2021 – Worldwide Clinical Trials, Inc. (Worldwide), the industry’s leading global, midsized, full-service contract research organization (CRO), today announced that its Vice President, Global Head of Regulatory Strategy Aman Khera has been recognized as one of the 100 Most Inspiring People in the Life Sciences Industry by PharmaVOICE.

Khera joined Worldwide in 2019 as a key member of the organization’s Scientific Solutions team with two decades of regulatory affairs experience, providing consultative services to biotech and pharmaceutical companies of all sizes. Concurrently, Khera is a sought-out mentor and thought leader within industry and volunteers with organizations such as DIA, The Organization for Professionals in Regulatory Affairs (TOPRA) and the Regulatory Affairs Professionals Society (RAPS). In all that she does, Aman champions the strategic role of regulatory professionals and advocates for diversity, inclusion and belonging in clinical research.

“Aman’s tireless efforts and pursuit of regulatory excellence have contributed to Worldwide’s continued growth and success,” said Henry Riordan, PhD, Chief Development Officer, Worldwide Clinical Trials. “She has set high standards for providing strategic regulatory guidance and developing and translating regulatory strategy into pragmatic solutions for sponsor companies. She commands respect because of her expert regulatory intelligence competence, her ability to solve complex regulatory problems swiftly, and most importantly, her passionate thought leadership.”

Since 2005, the PharmaVOICE 100 has identified and celebrated 1,600 of the life science industry’s most influential and inspirational professionals who have had a positive impact on the industry through their innovation and actions. The July/August issue of PharmaVOICE magazine each year shines a spotlight on the honorees’ passion and conviction for the industry, as well as their ability to translate industry trends into opportunities for breakthrough strategies and solutions.

“Congratulations to Aman Khera and the other 2021 PharmaVOICE 100 honorees,” said Peter Benton, President and co-CEO of Worldwide. “When we talk about Worldwide’s uncommon approach, it is our people, their passion and expertise that make it possible. We are incredibly fortunate to have Aman and so many extraordinary professionals on our team who have dedicated their careers to moving sponsors and the industry forward.”

For more information about Worldwide Clinical Trials and its team of industry-leading professionals, visit Worldwide.com.

About Worldwide Clinical Trials

Worldwide Clinical Trials employs 2,000+ professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia, and Asia-Pacific. Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way. From early phase and bioanalytical sciences through late phase, post-approval, and real-world evidence, we provide world-class, full-service drug development services.

With infrastructure and talent spanning 60 countries, we execute predictable, successful studies with operational excellence across a range of therapeutic areas, including central nervous system, cardiovascular, metabolic, general medicine, oncology, and rare diseases. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO. For more information, visit www.worldwide.com.

Media Contact:
MERGE for Worldwide Clinical Trials
Katie Schira

mergeworldwideteam@mergeworld.com